Artificial intelligence-enhanced drug design and development: Toward a computational precision medicine
Author:
Funder
Laboratoires Servier Research Centre Suresnes
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference74 articles.
1. Innovation in the pharmaceutical industry: new estimates of R&D costs;DiMasi;J Health Econ,2016
2. An analysis of the attrition of drug candidates from four major pharmaceutical companies;Waring;Nat Rev Drug Discov,2015
3. Artificial intelligence in drug development: present status and future prospects;Mak;Drug Discovery Today,2019
4. Applications of machine learning in drug discovery and development;Vamathevan;Nature Reviews Drug Discovery,2019
5. Artificial intelligence in drug discovery and development;Paul;Drug Discov Today,2021
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination of ligand‑based and structure‑based virtual screening for the discovery of novel Janus kinase 2 inhibitors against philadelphia-negative myeloproliferative neoplasms;Molecular Diversity;2024-08-29
2. P.O.L.A.R. Star: A New Framework Developed and Applied by One Mid-Sized Pharmaceutical Company to Drive Digital Transformation in R&D;Pharmaceutical Medicine;2024-08-09
3. Research on Artificial-Intelligence-Assisted Medicine: A Survey on Medical Artificial Intelligence;Diagnostics;2024-07-09
4. Harnessing the power of AI-based models to accelerate drug discovery against immune diseases;Expert Review of Clinical Immunology;2024-07
5. A Review on Artificial Intelligence in Pharmacy;Research Journal of Science and Technology;2024-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3